Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ALEMBIC PHARMA   TEVA PHARMA
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-23
TEVA PHARMA
Dec-13
ALEMBIC PHARMA/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs7923,479-   
Low Rs4633,022-   
Sales per share (Unadj.) Rs287.61,996.4-  
Earnings per share (Unadj.) Rs17.4124.7-  
Cash flow per share (Unadj.) Rs31.4286.1-  
Dividends per share (Unadj.) Rs8.00109.18-  
Avg Dividend yield %1.33.4 37.9%  
Book value per share (Unadj.) Rs222.32,217.6-  
Shares outstanding (eoy) m196.56848.00-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.21.6 134.1%   
Avg P/E ratio x36.126.1 138.5%  
P/CF ratio (eoy) x20.011.4 175.9%  
Price / Book Value ratio x2.81.5 192.7%  
Dividend payout %46.087.5 52.5%   
Avg Mkt Cap Rs m123,4022,756,220 4.5%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m11,6910-   
Avg. sales/employee Rs Th037,667.6-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th02,353.1-  
INCOME DATA
Net Sales Rs m56,5261,692,969 3.3%  
Other income Rs m300-   
Total revenues Rs m56,5571,692,969 3.3%   
Gross profit Rs m6,772463,620 1.5%  
Depreciation Rs m2,754136,844 2.0%   
Interest Rs m50233,253 1.5%   
Profit before tax Rs m3,546293,523 1.2%   
Minority Interest Rs m01,333 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-192,682 -0.0%   
Tax Rs m126-3,584 -3.5%   
Profit after tax Rs m3,420105,758 3.2%  
Gross profit margin %12.027.4 43.7%  
Effective tax rate %3.6-1.2 -291.3%   
Net profit margin %6.16.2 96.8%  
BALANCE SHEET DATA
Current assets Rs m29,1391,143,425 2.5%   
Current liabilities Rs m16,408997,163 1.6%   
Net working cap to sales %22.58.6 260.7%  
Current ratio x1.81.1 154.9%  
Inventory Days Days1091 10.7%  
Debtors Days Days796 7.0%  
Net fixed assets Rs m31,498552,961 5.7%   
Share capital Rs m3934,167 9.4%   
"Free" reserves Rs m43,3120-   
Net worth Rs m43,7051,880,567 2.3%   
Long term debt Rs m0865,653 0.0%   
Total assets Rs m60,6373,868,976 1.6%  
Interest coverage x8.19.8 82.1%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x0.90.4 213.0%   
Return on assets %6.53.6 180.0%  
Return on equity %7.85.6 139.1%  
Return on capital %9.34.9 187.8%  
Exports to sales %46.40-   
Imports to sales %12.10-   
Net fx Rs m19,3640-   
CASH FLOW
From Operations Rs m7,240269,772 2.7%  
From Investments Rs m-4,476-95,591 4.7%  
From Financial Activity Rs m-2,620-323,609 0.8%  
Net Cashflow Rs m144-149,429 -0.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare ALEMBIC PHARMA With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare ALEMBIC PHARMA With: PIRAMAL PHARMA  ABBOTT INDIA  PROCTER & GAMBLE HEALTH  MAKERS LAB.  SHELTER PHARMA  



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.